VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_20-vv-00776
Package ID: USCOURTS-cofc-1_20-vv-00776
Petitioner: Jaylah Black
Filed: 2020-06-25
Decided: 2026-01-02
Vaccine: human papillomavirus 9-valent (HPV9), tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal conjugate (Menactra), and influenza
Vaccination date: 2017-06-28
Condition: alleged acute cerebellar ataxia, acute vestibular neuropathy, AIDP, polyneuropathy, weakness, functional gait disorder, and conversion disorder
Outcome: dismissed
Award amount USD: 

AI-assisted case summary:
On June 25, 2020, Lorraine Ferrucci filed a petition on behalf of her then-minor granddaughter, Jaylah Black. The petition alleged that HPV9, Tdap, and Menactra vaccines administered on June 28, 2017, an influenza vaccine administered on October 31, 2017, and a second HPV9 vaccine administered on December 29, 2017 caused acute cerebellar ataxia, acute vestibular neuropathy, AIDP, polyneuropathy, weakness, functional gait disorder, conversion disorder, and related neurologic symptoms.

By 2025, Jaylah had reached the age of majority and did not want to continue the Vaccine Program case. In an unopposed motion to dismiss, she maintained that she had suffered injuries but stated that she intended to reject any Program judgment and pursue civil litigation in the Gardasil multidistrict litigation in North Carolina.

Special Master Herbrina D. S. Young dismissed the petition on January 2, 2026. The dismissal stated that the record was insufficient to support compensation, no Table claim had been established, and no medical opinion had been filed to support causation.

Theory of causation field:
HPV9, Tdap, and Menactra vaccines June 28, 2017; influenza October 31, 2017; second HPV9 December 29, 2017; then-minor Jaylah Black alleged acute cerebellar ataxia, acute vestibular neuropathy, AIDP, polyneuropathy, weakness, functional gait disorder, and conversion disorder. DISMISSED after Jaylah reached majority and chose not to proceed, intending civil litigation. No Table claim or medical causation opinion supported entitlement. SM Herbrina D. S. Young; petition June 25, 2020; decision January 2, 2026.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_20-vv-00776-0
Date issued/filed: 2026-01-26
Pages: 2
Docket text: PUBLIC DECISION (Originally filed: 1/2/2026) regarding 99 DECISION of Special Master. Signed by Special Master Herbrina D S Young. (gf) Service on parties made.
--------------------------------------------------------------------------------
Case 1:20-vv-00776-UNJ Document 106 Filed 01/26/26 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: January 2, 2026
* * * * * * * * * * * * * * * * * * * * * * * * *
LORRAINE FERRUCCI, *
on behalf of J.B., *
*
Petitioner, * Special Master Young
*
v. * No. 20-776V
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
* * * * * * * * * * * * * * * * * * * * * * * * *
Mark Theodore Sadaka, Law Offices of Sadaka Associates, LLC, Englewood, NJ, for Petitioner.
Sarah Christina Duncan, U.S. Department of Justice, Washington, DC, for Respondent.
DISMISSAL DECISION1
On June 25, 2020, Lorraine Ferrucci (“Petitioner”) filed a petition pursuant to the National
Vaccine Injury Compensation Program2 on behalf of her then minor granddaughter, Jaylah Black.
Pet., ECF No. 1. Petitioner alleged that the administration of human papillomavirus 9 (“HPV9”),
tetanus, diphtheria, pertussis (“Tdap”), and Menactra vaccines Ms. Black received on June 28,
2017, an influenza (“flu”) vaccine administered on October 31, 2017, and a second dose of HPV9
received on December 29, 2017 caused her to suffer from “vaccine-induced acute cerebellar ataxia,
acute vestibular neuropathy, ataxia, acute inflammatory demyelinating polyneuropathy,
polyneuropathy, weakness, functional gate disorder[,] and conversion disorder,” which was
caused-in-fact or significantly aggravated by the administration of the vaccines. Pet. at 1.
1Because this Decision contains a reasoned explanation for the action taken in this case, it must be made
publicly accessible and will be posted on the United States Court of Federal Claims’ website, and/or at
https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act
of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Decision will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that
the identified material fits within this definition, I will redact such material from public access.
2 The Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-
10 et seq. (hereinafter “Vaccine Act,” “the Act,” or “the Program”). Hereafter, individual section references
will be to 42 U.S.C. § 300aa of the Act.
1

Case 1:20-vv-00776-UNJ Document 106 Filed 01/26/26 Page 2 of 2
On January 27, 2025, Petitioner filed an unopposed motion for a decision dismissing her
petition. ECF No. 96. In her motion, Petitioner indicated that Ms. Black had now reached the age
of majority and indicated “she does not want to proceed with her vaccine petition.” Id. at 1.
Petitioner maintained that she continued to suffer from her alleged injuries as caused by the
vaccines alleged and that she would pursue her claim “in the Gardasil MDL in North Carolina.”
Id. Petitioner continued that she understood a dismissal of her claim would result in a judgment
against her, and that she intended to protect her rights to file a future civil action and thus intends
to elect to “reject the Vaccine Program judgment and elect to file a civil action” pursuant to 42
U.S.C. § 300aa-21(a)(2).
To receive compensation under the Program, Petitioner must prove either (1) that she
suffered a “Table Injury”—i.e., an injury falling within the Vaccine Injury Table—corresponding
to the vaccination, or (2) that she suffered an injury that was caused by a vaccine. See §§
13(a)(1)(A), 11(c)(1). Petitioner does not allege a Table claim. The record does not contain
persuasive evidence that Petitioner’s alleged injury was caused by the vaccines alleged.
Under the Act, petitioners may not be given a Program award based solely on their claims
alone. Rather, the petition must be supported by medical records or the opinion of a competent
physician. § 13(a)(1). In this case, the medical records are insufficient to prove Petitioner’s claim,
and Petitioner has not filed a supportive opinion from an expert witness. Therefore, this case must
be dismissed for insufficient proof. The Clerk shall enter judgment accordingly.3
IT IS SO ORDERED.
/s/ Herbrina D. S. Young
Herbrina D. S. Young
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of a notice
renouncing the right to seek review.
2